Phosphatidylethanolamines (bovine) are the second most abundant glycerophospholipids in eukaryotic cells, comprising 15 - 25% of total phospholipids in mammalian cells[1]. Phosphatidylethanolamines are multifunctional phospholipids required for mammalian development and are essential for a variety of cellular processes. These include serving as a precursor for phosphatidylcholine, acting as a substrate for important post-translational modifications, influencing membrane topology, promoting cell and organelle membrane fusion, supporting oxidative phosphorylation, facilitating mitochondrial biogenesis, and enhancing autophagy[2]. It was commonly used in studies related to Alzheimer's disease (AD), Parkinson's disease (PD), nonalcoholic fatty liver disease (NAFLD), and the virulence of certain pathogenic organisms[2].
Phosphatidylethanolamines (50μM, 96h) containing docosahexaenoic acid (DHA) enhanced cell differentiation and growth inhibition of HL-60 induced by dibutyryl cAMP (dbcAMP)[3]. Phosphatidylethanolamines (0.25 - 1mmol/L, 24 - 72h) inhibited the growth of HepG2 cells in a dose- and time-dependent manner[4]. Additionally, phosphatidylethanolamines (0.25 - 1mmol/L, 6 - 24h) up-regulated the expression of Bax and down-regulated the expression of Bcl-2 in HepG2 cells in a dose- and time-dependent manner[4].
Phosphatidylethanolamines (375mg/kg, i.p.) significantly inhibited food intake and locomotor activity in N-palmitoyl-phosphatidylethanolamine-hydrolysing phospholipase D knockout (NAPE-PLD−/−) mice model[5]. Phosphatidylethanolamines (2g added to 8g soybean oil, 15 - 18 days, ad libitum p.o.) caused a decrease in serum cholesterol, phospholipid, apolipoprotein A-I (apoA-I) and apoE, and an increase in high molecular weight apoB. Additionally, they altered the distribution patterns of phospholipid subclasses in the liver and fatty acid composition of hepatic and plasma phospholipids in rats[6].
References:
[1] Patel D, Witt SN. Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease. Oxid Med Cell Longev. 2017;2017:4829180.
[2] Calzada E, Onguka O, Claypool SM. Phosphatidylethanolamine Metabolism in Health and Disease. Int Rev Cell Mol Biol. 2016;321:29-88.
[3] Ishigamori H, Hosokawa M, Kohno H, et al. Docosahexaenoic acid-containing phosphatidylethanolamine enhances HL-60 cell differentiation by regulation of c-jun and c-myc expression. Mol Cell Biochem. 2005;275(1-2):127-133.
[4] Yao Y, Huang C, Li ZF, et al. Exogenous phosphatidylethanolamine induces apoptosis of human hepatoma HepG2 cells via the bcl-2/Bax pathway. World J Gastroenterol. 2009;15(14):1751-1758.
[5] Wellner N, Tsuboi K, Madsen AN, et al. Studies on the anorectic effect of N-acylphosphatidylethanolamine and phosphatidylethanolamine in mice. Biochim Biophys Acta. 2011;1811(9):508-512.
[6] Imaizumi K, Mawatari K, Murata M, et al. The contrasting effect of dietary phosphatidylethanolamine and phosphatidylcholine on serum lipoproteins and liver lipids in rats. J Nutr. 1983;113(12):2403-2411.
Phosphatidylethanolamines (bovine)是真核细胞中第二丰富的甘油磷脂,占哺乳动物细胞总磷脂的15% - 25%[1]。Phosphatidylethanolamines是一种多功能磷脂,对哺乳动物的发育至关重要,并且在多种细胞过程中发挥着必不可少的作用。这些作用包括作为磷脂酰胆碱的前体物质、作为重要翻译后修饰的底物、影响膜的拓扑结构、促进细胞和细胞器膜的融合、支持氧化磷酸化、促进线粒体的生物合成以及增强自噬作用[2]。它常用于与阿尔茨海默病(AD)、帕金森病(PD)、非酒精性脂肪肝病(NAFLD)以及某些病原体的毒力相关的研究[2]。
Phosphatidylethanolamines(50μM,96h)联合二十二碳六烯酸(DHA)可增强由双丁酰环磷腺苷(dbcAMP)诱导的HL-60细胞的分化和生长抑制[3]。Phosphatidylethanolamines(0.25 - 1mmol/L,24 - 72小时)以剂量和时间依赖的方式抑制了HepG2细胞的生长[4]。此外,Phosphatidylethanolamines(0.25 - 1mmol/L,6 - 24小时)以剂量和时间依赖的方式上调了HepG2细胞中Bax的表达,并下调了Bcl-2的表达[4]。
Phosphatidylethanolamines(375mg/kg,腹腔注射)显著抑制了N-棕榈酰磷脂酰乙醇胺水解磷脂酶D敲除(NAPE-PLD−/−)小鼠模型的食物摄入和运动活动[5]。Phosphatidylethanolamines(2g添加到8g大豆油中,自由口服,15 - 18天)导致大鼠血清胆固醇、磷脂、载脂蛋白A-I(apoA-I)和载脂蛋白E(apoE)水平降低,同时使高分子量载脂蛋白B(apoB)水平升高。此外,它还改变了大鼠肝脏中磷脂亚类的分布模式以及肝脏和血浆磷脂的脂肪酸组成[6]。
















